Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Nasdaq Real Time Price USD

Adicet Bio, Inc. (ACET)

Compare
0.5258
-0.0455
(-7.96%)
At close: April 17 at 4:00:01 PM EDT
0.5300
+0.00
+(0.80%)
After hours: April 17 at 6:16:54 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
--
24,990
9,730
Operating Expense
127,615
127,615
132,576
97,541
71,163
Operating Income
-127,615
-127,615
-132,576
-72,551
-61,433
Net Non Operating Interest Income Expense
10,710
10,710
9,953
3,680
-85
Other Income Expense
-217
-217
-20,035
-919
-606
Pretax Income
-117,122
-117,122
-142,658
-69,790
-62,124
Tax Provision
--
--
--
--
-125
Net Income Common Stockholders
-117,122
-117,122
-142,658
-69,790
-61,999
Diluted NI Available to Com Stockholders
-117,122
-117,122
-142,658
-69,790
-61,999
Basic EPS
-1.70
-1.33
-3.31
-1.70
-2.00
Diluted EPS
-1.70
-1.33
-3.31
-1.70
-2.00
Basic Average Shares
75,939.9430
87,866.4350
43,042.4050
41,080.2860
30,952.1520
Diluted Average Shares
75,939.9430
87,866.4350
43,042.4050
41,080.2860
30,952.1520
Total Operating Income as Reported
-127,615
-127,615
-152,038
-72,551
-61,433
Total Expenses
127,615
127,615
132,576
97,541
71,163
Net Income from Continuing & Discontinued Operation
-117,122
-117,122
-142,658
-69,790
-61,999
Normalized Income
-117,122
-117,122
-123,196
-69,790
-61,999
Interest Income
10,714
10,714
9,978
3,760
91
Interest Expense
4
4
25
80
176
Net Interest Income
10,710
10,710
9,953
3,680
-85
EBIT
-117,118
-117,118
-142,633
-69,710
-61,948
EBITDA
-110,650
-110,650
-136,535
-67,135
-60,410
Reconciled Depreciation
6,468
6,468
6,098
2,575
1,538
Net Income from Continuing Operation Net Minority Interest
-117,122
-117,122
-142,658
-69,790
-61,999
Total Unusual Items Excluding Goodwill
--
--
-19,462
--
--
Total Unusual Items
--
--
-19,462
--
--
Normalized EBITDA
-110,650
-110,650
-117,073
-67,135
-60,410
Tax Rate for Calcs
--
--
--
--
0
12/31/2021 - 1/26/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PMVP PMV Pharmaceuticals, Inc.
1.0200
+2.00%
 
NKTX Nkarta, Inc.
1.8100
+3.43%
 
LYEL Lyell Immunopharma, Inc.
0.4336
-1.23%
 
MRSN Mersana Therapeutics, Inc.
0.3547
+5.63%
 
ALEC Alector, Inc.
0.9201
-5.95%
 
ALXO ALX Oncology Holdings Inc.
0.5500
-1.79%
 
ABOS Acumen Pharmaceuticals, Inc.
0.9008
-8.08%
 
CTMX CytomX Therapeutics, Inc.
0.6560
+4.18%
 
OLMA Olema Pharmaceuticals, Inc.
4.4200
+3.76%
 
FATE Fate Therapeutics, Inc.
1.1100
+5.71%